Related Experiment Video

Updated: May 1, 2026

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death
09:18

Identification of Intracellular Signaling Events Induced in Viable Cells by Interaction with Neighboring Cells Undergoing Apoptotic Cell Death

Published on: December 27, 2016

7.9K

Activation of protease-activated receptor 2 reduces glioblastoma cell apoptosis

Ran Luo, Xiongwei Wang1, Yuanxun Dong

  • 1Department of Neurosurgery, Institute of Neurosurgery, Yichang Central People's Hospital & The First Clinical Medical College of Three Gorges University, Yichang, Hubei 443003, P,R, China. xiongweiwang4@163.com.

Journal of Biomedical Science
|March 28, 2014
PubMed
Abstract

Insights

Protease activated receptor-2 (PAR2) activation reduces glioma cell apoptosis by affecting p53 expression. This suggests PAR2 is a potential therapeutic target for glioma treatment.

Area of Science:

  • Neuro-oncology
  • Cellular biology
  • Molecular mechanisms of cancer

Background:

  • Glioma pathogenesis remains poorly understood, with apoptosis dysregulation significantly impacting tumor progression.
  • Understanding the molecular regulators of apoptosis is crucial for developing effective glioma therapies.

Purpose of the Study:

  • To investigate the role of protease activated receptor-2 (PAR2) in regulating apoptosis within glioma cells.
  • To elucidate the molecular pathways influenced by PAR2 activation in the context of glioma.

Main Methods:

  • Expression analysis of PAR2 in U87 glioma cells and human glioma tissues.
  • Treatment of U87 cells with tryptase or a PAR2-specific peptide.
  • Assessment of STAT3 phosphorylation, p53 expression, and apoptosis rates post-treatment.

Main Results:

  • PAR2 expression was confirmed in U87 cells and human glioma tissue.
  • PAR2 activation (via tryptase or peptide) led to increased STAT3 phosphorylation in irradiated U87 cells.
  • PAR2 activation suppressed U87 cell apoptosis and reduced p53 expression.

Conclusions:

  • PAR2 activation inhibits apoptosis in irradiated U87 cells by modulating p53 expression.
  • PAR2 represents a potential novel therapeutic target for glioma treatment.

More Related Videos

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control07:13

Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control

Published on: May 24, 2024

1.1K

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.2K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.2K
Enzyme-linked Receptors01:00

Enzyme-linked Receptors

Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
64.6K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
8.7K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K